Famygen Life Sci Company Profile
✉ Email this page to a colleague
What is the competitive landscape for FAMYGEN LIFE SCI, and when can generic versions of FAMYGEN LIFE SCI drugs launch?
FAMYGEN LIFE SCI has one approved drug.
There are six US patents protecting FAMYGEN LIFE SCI drugs.
There are twenty-one patent family members on FAMYGEN LIFE SCI drugs in sixteen countries.
Summary for Famygen Life Sci
| International Patents: | 21 |
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Famygen Life Sci
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Famygen Life Sci | RYZUMVI | phentolamine mesylate | SOLUTION;OPHTHALMIC | 217064-001 | Sep 25, 2023 | RX | Yes | Yes | 11,090,261 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Famygen Life Sci | RYZUMVI | phentolamine mesylate | SOLUTION;OPHTHALMIC | 217064-001 | Sep 25, 2023 | RX | Yes | Yes | 10,772,829 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Famygen Life Sci | RYZUMVI | phentolamine mesylate | SOLUTION;OPHTHALMIC | 217064-001 | Sep 25, 2023 | RX | Yes | Yes | 11,844,858 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Famygen Life Sci | RYZUMVI | phentolamine mesylate | SOLUTION;OPHTHALMIC | 217064-001 | Sep 25, 2023 | RX | Yes | Yes | 9,795,560 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Famygen Life Sci | RYZUMVI | phentolamine mesylate | SOLUTION;OPHTHALMIC | 217064-001 | Sep 25, 2023 | RX | Yes | Yes | 11,400,077 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Famygen Life Sci | RYZUMVI | phentolamine mesylate | SOLUTION;OPHTHALMIC | 217064-001 | Sep 25, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Famygen Life Sci | RYZUMVI | phentolamine mesylate | SOLUTION;OPHTHALMIC | 217064-001 | Sep 25, 2023 | RX | Yes | Yes | 10,278,918 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Famygen Life Sci Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2762153 | ⤷ Sign Up |
| Australia | 2019366451 | ⤷ Sign Up |
| Brazil | 112021007725 | ⤷ Sign Up |
| Japan | 6335927 | ⤷ Sign Up |
| Mexico | 2021004708 | ⤷ Sign Up |
| World Intellectual Property Organization (WIPO) | 2014121027 | ⤷ Sign Up |
| Australia | 2018200566 | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
